The type 2 immune response is triggered by intestinal helminth infection and is characterized by elevations in IL-4, IL-5, IL-13 and other Th2 cytokines. The factors that initiate the type 2 immune response are not yet well understood and may include release of danger associated molecular patterns, which may be triggered by tissue damage resulting from intestinal helminths migrating through body tissues. We have recently identified adenosine, specifically interacting with the A2B adenosine receptor (AR) as a potential danger associated molecular pattern that may be essential for the development of type 2 immune response to the intestinal nematode parasite, H. polygyrus. Our studies showed that the intestinal immune response to H. polygyrus is markedly impaired in A2BAR-/- mice and in wild-type mice given A2BAR antagonists. Our findings further indicate that mRNA upregulation of the cytokine alarmin, IL-33, is inhibited by A2BAR blockade, raising the possibility that one mechanism through which A2BAR signaling initiates type 2 immunity is through influencing IL-33 production. In our proposed studies we will examine the role of A2BAR signaling in triggering the release and subsequent upregulation of IL-33 gene and protein expression. We will further examine specific targets of A2BAR signaling, including epithelial cells and macrophages, and specifically examine how A2BAR affects the development of the type 2 primary and memory immune response to H. polygyrus. The mechanisms of adenosine accumulation, including release and degradation of its precursor ATP will also be studied. These studies will elucidate the role of adenosine as an endogenous danger signal in the initiation and the development of the mucosal type 2 immune response and as such will provide significant insights as to how this important type of immune response may develop.

Public Health Relevance

The type 2 immune response is triggered by intestinal helminth infection and mediates protection against helminths. We have shown that adenosine receptors, which are antenna-like structures on the cell surface that detect the purine molecule adenosine, are required for the development of the host protective immune response to helminths, providing a fundamental link between tissue damage and the initiation and maintenance of the type 2 immune response. These findings have important implications in terms of identifying potential pharmacological targets in the purinergic system for modulating type 2 immune responses during infection and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK113790-05
Application #
9983656
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Perrin, Peter J
Project Start
2017-08-01
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Csóka, Balázs; Németh, Zoltán H; Szabó, Ildikó et al. (2018) Macrophage P2X4 receptors augment bacterial killing and protect against sepsis. JCI Insight 3:
Antonioli, Luca; Blandizzi, Corrado; Pacher, Pál et al. (2018) Quorum sensing in the immune system. Nat Rev Immunol 18:537-538
Csóka, Balázs; Németh, Zoltán H; Duerr, Claudia U et al. (2018) Adenosine receptors differentially regulate type 2 cytokine production by IL-33-activated bone marrow cells, ILC2s, and macrophages. FASEB J 32:829-837
Haskó, György; Antonioli, Luca; Cronstein, Bruce N (2018) Adenosine metabolism, immunity and joint health. Biochem Pharmacol 151:307-313
Yap, George S; Gause, William C (2018) Helminth Infections Induce Tissue Tolerance Mitigating Immunopathology but Enhancing Microbial Pathogen Susceptibility. Front Immunol 9:2135
Csóka, Balázs; Tör?, Gábor; Vindeirinho, Joana et al. (2017) A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity. FASEB J 31:4985-4997